Children with cancer are missing out on precision medicine, study finds

24 September 2019 - Only a small number of children with solid tumour cancers are able to access targeted precision ...

Read more →

Inside drug makers' strategy to boost cancer medicines with 'Lazarus effect'

6 September 2019 - In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus ...

Read more →

FDA warns testing companies: don’t tell patients how their DNA influences response to specific drugs

28 August 2019 - Amid a boom in genetic testing that aims to predict a person’s response to medication, the ...

Read more →

Personalised treatments may be threatened by drug cost-containment proposals

18 July 2019 - President Trump has said he plans to issue an executive order to lower what the United ...

Read more →

$65 million to unlock the potential of personalised medicine through genomics

26 March 2019 - The Australian Government will provide over $65 million in competitive research grants to Australia’s best and brightest ...

Read more →

Are we being misled about precision medicine?

12 September 2018 - Doctors and hospitals love to talk about the cancer patients they’ve saved, and reporters love to write ...

Read more →

Scotland could be 'world leader' in precision medicine, says First Minister

9 September 2018 - Scotland has the potential to be a "world leader" in precision medicine, according to the first ...

Read more →

Comparison of two treatment models: precision medicine and preventive medicine

28 August 2018 - In an effort to improve the risk-benefit profile of therapies in clinical care, precision medicine seeks to ...

Read more →

Precision medicine success hinges on diagnostics' clinical utility

23 July 2018 - The companion diagnostic plays a significant role in precision medicine.  ...

Read more →

$50 million to provide life-saving support to cancer patients

18 July 2018 - The Australian Government will provide $50 million to support some of Australia’s sickest patients, battling the most ...

Read more →

Federal Government to announce $50 million custom cancer drug trial

17 July 2018 - Almost 600 Queenslanders will have their cancer’s DNA tested to identify the drugs that will keep ...

Read more →

Personalised medicine and pay for performance: should pharmaceutical firms be fully penalised when treatment fails?

17 June 2018 - In this article, we model the behaviour of a pharmaceutical firm that has marketing authorisation for a ...

Read more →

August 2018 PBAC special meeting - invitation for submissions open and background paper available

21 May 2018 - PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types. ...

Read more →

Evolving landscape of US FDA drug approval in the era of precision oncology: finding the right balance between access and safety

15 May 2018 - Since 1992, the US FDA has implemented several programs for streamlined review and approval of agents that ...

Read more →

Precision medicines have faster approvals based on fewer and smaller trials than other medicines

7 May 2018 - Precision medicines can benefit patients by increasing the probability of a successful treatment response in selected patient ...

Read more →